Ciraparantag Completed Phase 2 Trials for Anticoagulation Reversal Other

IndicationsStatusPurposePhase
CompletedOther2
clinicaltrials.gov IdentifierTitleDrugs
NCT02207257Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban